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Abstract
Objectives: This study aimed to identify differences in absolute neutrophils, lymphocytes, and neutrophil-to-lymphocyte
ratio between neonates with two forms of ischemic brain injury, hypoxic-ischemic encephalopathy, and acute ischemic stroke,
compared to controls. We also aimed to determine whether this neutrophil/lymphocyte response pattern is associated with
disease severity or is a consequence of the effects of total-body cooling, an approved treatment for moderate-to-severe
hypoxic-ischemic encephalopathy.
Methods: A retrospective chart review of 101 neonates with hypoxic-ischemic encephalopathy + total-body cooling (n = 26),
hypoxic-ischemic encephalopathy (n = 12), acute ischemic stroke (n = 15), and transient tachypnea of the newborn (n = 48)
was conducted; transient tachypnea of the newborn neonates were used as the control group. Absolute neutrophil count
and absolute lymphocyte count at three time-intervals (0–12, 12–36, and 36–60 h after birth) were collected, and neutrophilto-lymphocyte ratio was calculated.
Results: Hypoxic-ischemic encephalopathy + total-body cooling neonates demonstrated significant time-interval-dependent
changes in absolute lymphocyte count and neutrophil-to-lymphocyte ratio levels compared to transient tachypnea of the
newborn and acute ischemic stroke patients. Pooled analysis of absolute lymphocyte count for neonates with acute ischemic
stroke and hypoxic-ischemic encephalopathy (not hypoxic-ischemic encephalopathy + total-body cooling) revealed that
absolute lymphocyte count changes occurring at 0–12 h are likely due to disease progression, rather than total-body cooling
treatment.
Conclusion: These data suggest that the neutrophil/lymphocyte response is modulated following neonatal ischemic brain
injury, representing a possible target for therapeutic intervention. However, initial severity of hypoxic-ischemic encephalopathy
among these patients could also account for the observed changes in the immune response to injury. Thus, additional work
to clarify the contributions of cooling therapy and disease severity to neutrophil/lymphocyte response following hypoxicischemic encephalopathy in neonates is warranted.
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Introduction
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Hypoxic-ischemic encephalopathy (HIE) and acute ischemic
stroke (AIS), both neonatal ischemic brain injury (IBI), have
yearly incidences of 1–6/1000 and 1/4000 live births, respectively.1,2 Although the two conditions reflect different pathophysiological processes initially (HIE is a global ischemic
insult, whereas AIS is a focal brain injury),1,3,4 their postinsult pathways yield many similarities: approximately 12–
36 h post-injury, peak impairment of brain perfusion triggers
a secondary cascade of inflammatory events irreversibly
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injuring neurons1 and leading to lifelong disabilities associated with motor deficits and intellectual impairment, or even
death.1–4 Understanding the pathological mechanisms of
neonatal IBI could optimize interventions that limit neuronal
damage.
Changes in immune response could be a crucial factor in
IBI pathology. Following IBI, soluble pro-inflammatory
molecules, such as cytokines, chemokines, oxidants, and
proteases, signal for neutrophils and lymphocytes to migrate
to the injured brain region.5 Currently, individual subsets of
leukocytes (e.g. neutrophils and lymphocytes) have been
studied within the context of neonatal IBI.6–8 Trends of
increased neutrophil counts post-injury (approximately
12 h) have been reported, followed by a noted decline
(between 24 and 72 h after insult) of these cells.6,7
Lymphocyte counts are also reported as elevated among
neonates with IBI within a similar time window of, but generally after, neutrophils.6,8 Approximately 36 h post-HIEinjury, the effects of hypothermia treatment are apparent on
both neutrophil and lymphocyte profiles, which both exhibit
suppressed phenotypes.6 Induced hypothermia, or totalbody cooling (TBC), is a known treatment for moderate-tosevere HIE, with well-documented beneficial impacts on
outcome.1,9,10
Among adult patients, a higher neutrophil-to-lymphocyte
ratio (NLR) has been linked to stroke and has shown to be
predictive of poorer outcome.11,12 Yet, fundamental differences in mature versus immature brains may impact the IBIinduced immune response in neonates;13 therefore, this
represents an important area of study in this population.
Although changes in individual leukocyte (e.g. neutrophil
and lymphocyte) profiles and their related cytokines have
been reported,6–8 NLR profiles have not been systematically
investigated in neonates with IBI. Here, we retrospectively
examined differences in absolute neutrophil count (ANC)
and absolute lymphocyte count (ALC) and their possible
influence on NLR in the neonatal population to determine
whether these measures support earlier diagnosis or quantify
disease severity.

Methods
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TBC protocol
Qualifying criteria for hypothermia according to a published
protocol included the presence of acute perinatal event, low
blood gas or cord pH, and moderate to severe encephalopathy confirmed by two independent neurological examinations. Therapeutic hypothermia was initiated within 6 h of
birth to achieve and maintain an esophageal temperature of
33.5°C for a period of 72 h followed by gradual re-warming
over a period of 6 h (see Appendix 1 for the full protocol).9

Inclusion and exclusion criteria
Neonates with gestational ages of less than 36 weeks, major
congenital malformations, metabolic conditions, or any
infections were excluded. Mothers with infections or those
treated with immunosuppressive or other immune systemaltering drugs were also excluded.

Data collection
A total of 101 patients were identified via International
Classification of Diseases, Ninth Revision (ICD-9) codes,
charts were reviewed, and HIE severity was determined.14
ALC and ANC from the complete blood count with differential from birth to 60 h after were collected, and NLR was
calculated for each patient. The post-birth values of ALC,
ANC, and NLR were divided into three time-intervals (0–12,
12–36, and 36–60 h) chosen based on documented alterations of these immune cells following birth.15,16 If a patient
had two + blood draws within one 12-h interval, the average
of those values was recorded.

Statistical analysis
Data were analyzed using SPSS (Version 19.0). Group differences (p < 0.05) among diagnosis (HIE + TBC, HIE, AIS, and
TTN) groups at each time-interval (0–12, 12–36, and 36–60 h
following birth) were tested using analysis of variance
(ANOVA) for each dependent variable. Significant diagnosis
main effects were followed up with post-hoc analyses using
the Bonferroni correction (significant at p < 0.0083).

Patients

Results

This retrospective analysis of clinical data existing in electronic medical records at West Virginia University Hospitals
was approved by the Institutional Review Board. A search
using the Epic Electronic Health Record system was performed to identify neonates with HIE (who did or did not
receive therapeutic hypothermia), AIS, and transient tachypnea of the newborn (TTN) admitted between 2004 and 2014.
TTN patients served as the comparison group given that they
are admitted for respiratory distress not associated with
ischemic pathology.

Neonatal demographics
Table 1 contains information regarding resuscitation rates,
APGAR (appearance, pulse, grimace, activity, respiration)
scores, and blood pH levels; Ns for each time-interval are
listed in Table 2. HIE + TBC neonates tended to score worse
than other groups on each of these measures. Histograms
of disease severity indicate that HIE + TBC patients
(Figure 1(a)) were generally more severe than HIE patients
(Figure 1(b)).
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Table 1. Neonatal patient demographics.
Groups

GA
(weeks)

Sex

Res (%)

APGAR:
1 min

APGAR:
5 min

Delivery (%)

pH

Sepsis workup (%)

Temperature
(°C)

TTN
AIS
HIE
HIE + TBC

38.4
38.8
39.1
38.8

28M: 20F
9M: 6F
8M: 4F
15M: 11F

14.6
13.3
58.3
80.8

6.7
6.6
2.9
1.8

8.0
8.8
5.0
3.2

47.9 SVD: 52.1 C/S
46.7 SVD: 53.3 C/S
50.0 SVD: 50.0 C/S
57.7 SVD: 42.3 C/S

7.3
7.3
7.3
7.1

0
0
0
11.5

37.0
36.9
36.7
35.1

HIE: hypoxic-ischemic encephalopathy; TBC: total-body cooling; AIS: acute ischemic stroke; TTN: transient tachypnea of the newborn; GA: gestational
age; Res: resuscitation; APGAR: appearance, pulse, grimace, activity, respiration; SVD: spontaneous vaginal delivery; C/S: caesarean-section; pH: arterial
and/or venous or cord blood gas.

Table 2. Subject numbers for each of the three time-intervals.
Groups

0–12 h

12–36 h

36–60 h

TTN; n = 48
AIS; n = 15
HIE; n = 12
HIE + TBC; n = 26

28
7
7
25

26
7
7
20

11
9
4
13

HIE: hypoxic-ischemic encephalopathy; TBC: total-body cooling; AIS:
acute ischemic stroke; TTN: transient tachypnea of the newborn.

Neutrophil/lymphocyte/NLR response among
neonatal patient populations
Immune cells were altered in distinct patient populations in a
time-interval-dependent manner across the acute injury
period. Specifically, during the 0–12 h time-interval, there
was a significant diagnosis effect for ALC (F(3, 63) = 4.80,
p < 0.005) (Figure 2(a)), but not ANC (Figure 2(c)) nor NLR
(Figure 2(e)). Post-hoc analyses revealed elevated ALC
among HIE + TBC neonates relative to TTN patients.
This trend was also observed during the 12–36 h timeinterval. During this time, there was a significant diagnosis
effect for ALC (F(3, 56) = 7.37, p < 0.001) (Figure 2(a)) but
not ANC nor NLR. Post-hoc analyses revealed lowered ALC
among HIE + TBC neonates relative to the TTN and AIS
groups.
During the 36–60 h time-interval, there was a significant
diagnosis effect for ALC (F(3, 33) = 5.04, p < 0.005) (Figure
2(a)). Post-hoc analyses revealed lowered ALC among
HIE + TBC neonates relative to TTN patients. As well, there
was a diagnosis effect for NLR (F(3, 33) = 3.66, p < 0.05)
(Figure 2(e)). Post-hoc analyses revealed elevated NLR
among HIE + TBC neonates relative to TTN patients. There
were no effects of diagnosis on ANC.
That the HIE + TBC group had elevated immune cell
counts at the early time-point initially could suggest that
TBC exacerbates the immune response in neonatal HIE
patients. This was a surprising finding considering that TBC
is a known beneficial therapeutic intervention for HIE.1,9,10
Therefore, although mechanisms of injury differ in the two
brain injury conditions,1,3,4 post-hoc we pooled data from
patients from our sample who had sustained any kind of

cerebral ischemia but did not undergo cooling therapy (AIS
and HIE groups not including HIE + TBC) and assessed
changes in ALC, ANC, and NLR relative to TTN patients at
each time-interval to dissociate the impact of ischemic injury
(of any kind) versus the addition of TBC treatment in
ischemic brain injured neonates on immune markers.
Between 0–12 h, there was a significant diagnosis effect for
ALC (t(40) = 2.68, p < 0.05) (Figure 2(b)) but not ANC
(Figure 2(d)) nor NLR (Figure 2(f)).

Discussion
These preliminary findings support that activation of the
immune system is an important component of IBI. Indeed,
immune modulation following stroke is documented in
adults; NLR is used as a diagnostic indicator of stroke, cancer, infection, and other pathologies.11–12,17–20 However, the
immune response of neonatal IBI is not well characterized.
Moreover, IBI-related differences between adult and neonatal populations are broadly attributed to the polarized states
of immune system and brain maturity. Specifically, following IBI in both populations, pro-inflammatory molecules act
as signaling molecules for subsets of leukocytes, such as
neutrophils and lymphocytes, which then migrate to the
injured brain region.5 However, known differences in these
ischemic pathways are associated with adults and neonatal
populations.13 For example, after neonatal ischemic insult in
the form of AIS, activated, resident microglial cells, rather
than peripheral invading monocytes, are the primary immune
cells that initiate the pro-inflammatory cascade.20 These activated microglia produce pro-inflammatory cytokines and
chemokines, which, in turn, increase the magnitude of neutrophil chemotaxis to the injured area, and are a crucial component to subsequent lymphocyte activation.13,20,21
Additionally, there are also differences in neutrophil and
lymphocyte adherence and migration following ischemic
insult between the two populations. Such an example can be
observed in the neutrophil populations of post-natal day 7 rat
pups, where, in contrast to adults, neutrophils are not found
to migrate to the brain within the early hours of post HIEinjury, but do migrate following AIS-injury. In both populations, there is evidence that lymphocytes migrate to the brain
later than neutrophils, although this migration is more
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Figure 1. (a) Histogram of HIE + TBC severity. Among HIE + TBC patients for whom level of ischemic severity was determined (n = 23),
there were 2 mild, 12 moderate, and 9 severe cases; (b) Histogram of HIE severity. Among HIE patients for whom level of ischemic
severity was determined (n = 7), there were four mild, one moderate, and two severe cases.

Figure 2. Time-point-dependent alterations in absolute neutrophil and lymphocyte counts among patient populations. (a) Mean ± SEM
ALC in each patient population. At the 0–12 h time-interval, ALC are elevated in HIE + TBC (M = 7.81, SD = 4.21) versus TTN (M = 4.29,
SD = 2.09) neonates. At the 12–36 h time-interval, ALC are lower in HIE + TBC (M = 1.96, SD = 0.99) versus TTN (M = 3.73, SD = 1.4) and
AIS (M = 3.73, SD = 0.66) neonates. At the 36–60 h time-interval, ALC are lower in HIE + TBC (M = 2.18, SD = 1.16) versus TTN (M = 5.08,
SD = 2.81) neonates. (b) Mean ± SEM ALC in AIS/HIE relative to TTN. At the 0–12 h time-interval, ALC are elevated in AIS/HIE (M = 6.80,
SD = 4.01) versus TTN (M = 4.29, SD = 2.09) neonates. These findings suggest that changes in ALC at the 0–12 h time-interval are due
to ischemic injury rather TBC treatment. (c) Mean ± SEM ANC in each patient population. There were no significant group differences
between each patient group in ANC for any of the three time-intervals. (d) Mean ± SEM ANC in AIS/HIE relative to TTN. There were
no significant group differences between each patient group in ANC for any of the three time-intervals. (e) Mean ± SEM NLR in each
patient population. At the 36–60 time-interval, NLR are lower in HIE + TBC (M = 5.72, SD = 3.09) versus TTN (M = 2.76, SD = 1.70)
neonates. (f) Mean ± SEM NLR in AIS/HIE relative to TTN. There were no significant group differences between each patient group in
NLR for any of the three time-intervals. a = significant (Bonferroni corrected p < 0.0083) versus TTN at that time-interval; b = significant
(Bonferroni corrected p < 0.0083) versus AIS at that time-interval.
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prominent in adults than in neonates.13 Additional neonatal
animal studies report that modulation of neutrophils and
lymphocytes does occur within the post-ischemic injury
period, and that these modulations are often associated with
injury severity and long-term neurological outcome.22–24
Furthermore, although one study conducted in term infants
with HIE found no correlation between lymphocyte number
and outcome,8 findings from another noted that elevated
peripheral neutrophils were associated with worsened neurological outcome.7 Methodological and/or population differences between these and the current study (i.e., severity was
not measured in Morkos et al.7 and Shah et al.8) could
account for these discrepant findings.
Here, we noted a time-interval-dependent shift in lymphocyte counts among the HIE + TBC patients relative to neonates with AIS or TTN. This effect is possibly due to TBC
treatment. However, given that the beneficial effects of TBC
on clinical outcome following IBI are known,25 our finding is
not likely attributable to the effect of TBC but rather due to
either the presence of an ischemic injury and/or increased IBI
severity we noted in the HIE + TBC group. Specifically, in the
initial post-injury hours, we report increased ALC among
HIE neonates that received TBC, suggesting an impact due to
TBC treatment. However, when we assessed changes in ALC
following ischemia in only untreated IBI patients (AIS and
HIE groups), the increase in ALC was significant. The specificity of this significant increase at the first time-interval (0–
12 h) suggests that the difference noted in the TTN versus
HIE + TBC groups at that time-interval was likely due to the
presence of IBI; the cause (ischemic injury presence/severity
or effects of cooling intervention) of the changes noted at
later time-intervals in ALC (12–36 and 36–60) and NLR are
not completely clear from these data. Between 12–36 h, ALC
was significantly lower in HIE + TBC relative to comparison
groups. At the 36–60 h time-interval, the NLR was altered in
this group, a finding consistent with the noted increased NLR
that is associated with worsened clinical outcomes in adult
patients.11,12 While our findings are in partial congruence with
leukocyte profiles of other studies, specifically lymphocyte
counts,6,8 discrepancies between our work and the work of
others (i.e. significantly elevated ANC at the 12–24 h timepoint,7 a finding that we did not replicate here) regarding neutrophils could be attributed to differential time-point
groupings, IBI severity distribution differences, and a lack of
repeated measures due to small N as further described in the
“Limitations” section. Further supporting the notion that
presence/severity of IBI may be accounting for our observed
group differences (at least in the early time-intervals) is that
while 43% of HIE patients were considered moderate-tosevere, 92% of HIE + TBC patients met this criteria.
Furthermore, HIE + TBC neonates had the highest resuscitation rates, poorest APGAR scores, and lowest blood pH levels (Table 1). Thus, severity may be a key factor in the
pathological progression of hypoxic brain injury and should
be a covariate in future studies aimed at evaluating the

immune profile shifts in neonatal IBI patients. Taken together
with the published findings of others,6,8 these data suggest
that shifts in peripheral neutrophil and/or lymphocyte numbers may be important in the immune response following IBI;
more work is needed to clarify this effect, explore the possibility of these markers to be used as a biomarker for HIE
diagnosis/severity, and identify potential avenues for therapeutic targeting of these cells.

Limitations
Potential limitations of these findings are lack of repeated
measures for patients and small N values within particular
patient groups, leading to low statistical power. This study
was designed to assess changes in neutrophil/lymphocyte
profiles across the acute injury period in multiple IBI diagnoses. However, repeated blood draws for the TTN groups is
not standard practice given that TTN neonates are relatively
healthy with the exception of minor reversible respiratory
distress. Moreover, during the retrospective data collection
window, there were limited numbers of AIS and HIE cases
from which to gather data, limiting sample sizes in these
groups at several of the time-intervals assessed. Generally,
statistically significant comparisons noted here were between
TTN and HIE + TBC groups with the largest sample sizes.
This together with our use of a stringent and conservative
post-hoc test suggests that comparisons involving other
groups (i.e. AIS, HIE) may have been underpowered. This
low statistical power may also explain the lack of significant
alterations in ANC levels in the current study that has been
shown in other clinical reports.6,7 Additional work with
larger patient populations from whom data regarding immune
cell changes across time are gathered may reveal more pronounced effects of IBI, especially among the AIS and HIE
groups. Regardless, where converging findings agree is that
a profound immune response following neonatal hypoxic
ischemia takes place in the acute injury period, and that this
response could be used as a biomarker for HIE severity or
even a possible target for novel therapeutic interventions
aimed at reducing mortality and improving functional
outcomes.

Conclusion
Our results support the hypothesis that the neutrophil/lymphocyte response is altered following neonatal IBI, representing a possible target for therapeutic intervention. Future
work dissociating the benefits of TBC from injury severity
on neutrophil/lymphocyte profiles in IBI patients is
warranted.
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Moderate encephalopathy
Level of consciousness
Spontaneous activity
Posture
Tone
Primitive reflexes
Autonomic system

Lethargic
Decreased activity
Distal flexion
Full extension
Hypotonia focal, general
Weak suck
Incomplete Moro
Constricted pupils
Bradycardia
Periodic breathing

Appendix 1
Cooling protocol
Clinical findings include a cord pH or blood gas at <1 h of
age, with a pH < 7.0 or base deficit > 16 mEq/L. If a blood gas
is not available or pH is between 7.01 and 7.15 or base deficit of 10–15.9, the infant should have had an acute perinatal
event and either an APGAR score of <5 at 10 min or continued need for assisted ventilation for >10 min. If these criteria
are met, neurological examination is performed by two independent neonatologists or pediatric neurologist is obtained,
to define moderate and severe encephalopathy according to
seizures or presence of one or more signs in three of the six
categories as follows:
Therapeutic hypothermia is initiated in eligible infants as
soon as possible within 6 h of birth to achieve and maintain
an esophageal temperature of 33.5°C for a period of 72 h followed by gradual re-warming by increasing the core body
temperature at the rate of 0.5°C per hour over a period of 6 h.

Severe encephalopathy
Stupor/coma
No activity
Decerebrate
Flaccid
Absent suck
Absent Moro
Skew deviation, dilated, non-reactive
to light pupils
Variable heart rate
Apnea

The FDA-approved Blanketrol II Hyper/Hypothermia
System (manufactured by Cincinnati Sub-Zero) is the hypothermia device for thermoregulation. The infant is placed on a
cooling blanket in an open warmer with no layers of clothing
between the infant and the cooling blanket. Cooling blanket
should lie flat with no kinks in the connecting hoses. Infant
should lay supine on the blanket. An esophageal probe will
then be used to measure the set point esophageal temperature
which should be at 33.5°C. Fluctuations in this temperature
are to be expected but should not be greater than 1°C from the
set point. Once the set point is reached, a thin layer (such as a
receiving blanket) may be placed on the infant. Temperatures
from the esophageal probe, infant’s skin, and the cooling blanket will be monitored every 15 min for the first 4 h of therapy.
Temperatures will then be recorded hourly until 12 h of cooling and then every 2 h until the infant has completed the 72 h
of cooling therapy. Upon completion of 72 h cooling period,
the infant will be re-warmed gradually so that the core body
temperature will increase 0.5°C each hour over a 6 h period.

